Carlos Ramos is Hematologist at Baylor College of Medicine. ClinicalTrials.gov lists 17 registered studies with this person as an investigator.
Data verified 13 Nov 2026
Overview
Updated 13 Nov 2026
Carlos Ramos, MD, is Hematologist at Baylor College of Medicine. It also documents an investigator role on 17 registered clinical trials, industry payments reported by 9 companies, 2 NIH-funded awards (2010–2026).
- Top research focus: Lymphoma
- 17 registered trials on ClinicalTrials.gov
- Open Payments reporting from 9 companies
Generated from the cited public record · current as of 13 Nov 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Research metrics need a complete publication history and a confident author match. We omit them when either check fails. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 13 Nov 2026
Listed as an investigator on 17 registered studies on ClinicalTrials.gov. The most recent:
- Allogeneic NK T-Cells Expressing CD19 Specific CAR in B-Cell Malignancies
Sponsor: Athenex, Inc.
Industry payments
Updated 13 Nov 2026
9 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Kite Pharma, Inc.Program year20251 payment
- Celgene CorporationProgram year20251 payment
- NOVARTIS PHARMACEUTICALS CORPORATIONProgram year20231 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
34.9%Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor24.5%Valacyclovir100%Part D<11 patientsAzole Antifungal10.4%Fluconazole100%Part D<11 patientsNervous system
33%Gabapentinoids22.6%Gabapentin100%Part D<11 patientsSNRI10.4%Duloxetine Hcl100%Part D<11 patientsMetabolism & gastrointestinal
20.8%Bile Acid10.4%Ursodiol100%Part D<11 patientsSerotonin-3 Receptor Antagonist10.4%Ondansetron Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 13 Nov 2026
2 NIH research awards on record, funded 2010–2026 per NIH RePORTER. The latest:
- Acquisition of a Seahorse XF Pro Analyzer for Biomedical Research and Education in Metabolic Profiling
University of Puerto Rico Med Sciences
FY2026$249,961S10GM164872 - Nanotechnology enabled quantitative imaging of dendritic cell anti-cancer vaccines
University of Florida
FY2025$2,628,974R01CA298804
Publications
None on file yet. We only list publications we can confidently match to this person. Why? →
Background & recognition
Updated 13 Nov 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →healthgrades.com ↗
Secondary affiliations
appointments beyond the home institution- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →blogs.bcm.edu ↗
Media & interviews
press, podcasts and appearances- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →vumedi.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Christie Ballantyne, MD
Baylor College of Medicine
Joseph Jankovic, MD
Baylor College of Medicine
Hashem El-Serag, MD, MPH
Baylor College of Medicine
Biykem Bozkurt, MD
Baylor College of Medicine
Seth Steinberg, PhD
National Cancer Institute (NCI)
Gilles Salles
Memorial Sloan Kettering Cancer Center
Julie Vose, MD
University of Nebraska Medical Center
Bruce Cheson, MD
The Center for Cancer and Blood Disorders